Thomas DesRosier, Chief Legal Officer and EVP at Seres Therapeutics, Inc. (MCRB), sold 79 shares at $7.28 ($575) on 2025-05-15, disclosed to the SEC on 2025-05-19.
Scheduled sale ($575) by Chief Legal Officer and EVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| MCRB | SELL | 2026-02-18 | $661 | — | Filing → |
| MCRB | SELL | 2025-11-18 | $1K | — | Filing → |
| MCRB | SELL | 2025-08-19 | $1K | — | Filing → |